May 15 |
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
|
May 9 |
Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
May 8 |
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
|
May 8 |
Heron Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
May 8 |
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ...
|
May 7 |
Heron Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 7 |
Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript
|
May 7 |
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates
|
May 7 |
Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
|
May 7 |
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
|